FSD Pharma Inc (CNSX:HUGE – Get Rating) Director Zeeshan Saeed bought 23,000 shares of the company’s stock in a transaction on Thursday, April 13th. The stock was bought at an average cost of $2.52 per share, for a total transaction of $57,960.00. FSD Pharma Price Performance About FSD Pharma (Get Rating) FSD Pharma Inc operates […]
FSD Pharma Inc (CNSX:HUGE – Get Rating) Director Anthony John Durkacz acquired 50,000 shares of FSD Pharma stock in a transaction dated Monday, April 25th. The stock was bought at an average price of $1.25 per share, for a total transaction of $62,500.00. Following the completion of the transaction, the director now directly owns 273,597 […]
FSD Pharma Inc (CNSX:HUGE – Get Rating) Director Zeeshan Saeed purchased 8,584 shares of the company’s stock in a transaction on Thursday, April 21st. The shares were bought at an average cost of $1.40 per share, with a total value of $12,017.60. Following the transaction, the director now directly owns 477,360 shares of the company’s […]
FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc (CSE:HUGE) (NASDAQ:HUGE) Interim CEO Anthony Durkacz tells Proactive the group is to buy Canada-based specialty.
FSD Pharma appoints Adnan Bashir as an independent company director
Bashir, a former general manager of Dubai-based business conglomerate Al Batha group, has more than 14 years of experience in strategic management and operations FSD Pharma said Bashir was appointed to fill the vacancy on the board following the resignation of Frank Lavelle
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9) announced it has appointed Adnan Bashir as an independent member of the company’s board of directors.
Bashir, a former general manager of Dubai-based business conglomerate Al Batha group, has more than 14 years of experience in strategic management and operations.